LDX - Receives second $5MillionUSD payment from Hologic for FFN testing.
This takes the calendar year revenue to circa $16.59MillionAUD.
Cash flow positive and no remaining debts.
Unlikely for a CR in the short - mid term now.
Total funding available circa $11M USD.
